Ceftaroline
Drug Safety
Keith A. RodvoldSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Drug Safety cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Decitabine Jianxiang Wang | Phase 3 | B |
Anti-Grp78 Monoclonal Igm Antibody Pat-Sm6 Patrys Ltd. | Phase 1 | NR |
Same molecule, other indications
Ceftaroline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →